Nyxoah (NYXH) Shares Outstanding (Weighted Average) (2020 - 2026)
Nyxoah (NYXH) recorded quarterly Shares Outstanding (Weighted Average) of $0.43 in Q1 2026, down 100.0% quarter-over-quarter from $50.1 million in Q4 2025, and down 31.32% on a YoY basis from $0.63 in Q1 2025.
Nyxoah (NYXH) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Nyxoah's Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $0.43 for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) fell 31.32% year-over-year to $0.43; the TTM figure through Mar 2026 stood at $0.43 (down 31.32% YoY), while the FY2025 annual figure was $50.1 million, up 628.92% from the prior year.
- Shares Outstanding (Weighted Average) was $0.43 for Q1 2026 at Nyxoah, down from $50.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $50.1 million in Q4 2025 to a low of $0.29 in Q1 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $5.2 million across 5 years, with a median of $0.99 in 2023.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) sank 99.93% in 2022, then jumped 120856.88% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $25506.2 in 2022, then jumped by 120856.88% to $30.9 million in 2023, then sank by 77.73% to $6.9 million in 2024, then jumped by 628.92% to $50.1 million in 2025, then tumbled by 100.0% to $0.43 in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $0.43 (Q1 2026), $50.1 million (Q4 2025), and $2.08 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 354.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 283.14 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 819.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.34 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 174.20 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.43 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | 0.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.43 |
| Dec 31, 2025 | 50.08 Mn |
| Sep 30, 2025 | 2.08 |
| Jun 30, 2025 | 1.30 |
| Mar 31, 2025 | 0.63 |
| Dec 31, 2024 | 6.87 Mn |
| Sep 30, 2024 | 1.48 |
| Jun 30, 2024 | 0.91 |
| Mar 31, 2024 | 0.45 |
| Dec 31, 2023 | 30.85 Mn |
| Sep 30, 2023 | 1.27 |
| Jun 30, 2023 | 0.99 |
| Mar 31, 2023 | 0.49 |
| Dec 31, 2022 | 25,506.18 |
| Sep 30, 2022 | 0.70 |
| Jun 30, 2022 | 0.48 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 29.48 Mn |
| Sep 30, 2021 | 1.09 |
| Jun 30, 2021 | 686.43 |